<DOC>
	<DOCNO>NCT01398956</DOCNO>
	<brief_summary>The investigator provide Levetiracetam treatment epilepsy subject Japan judge benefit continued treatment Levetiracetam investigator willing continuously receive drug .</brief_summary>
	<brief_title>An Open Label Study L059 ( Levetiracetam ) Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>The subject Japan complete either study N01159 N01363 discontinue N01159 study due lack efficacy . The subject judge benefit continue treatment Levetiracetam investigator Subjects multiple protocol deviation N01159 N01363 , miss laboratory data , low noncompliance study medication , investigator considers potential deviation stop ineligible</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Levetiracetam</keyword>
	<keyword>Epilepsy</keyword>
	<keyword>Generalized tonic-clonic seizure</keyword>
</DOC>